Literature DB >> 3099562

Effects of flecainide on the cellular electrophysiology of neonatal and adult cardiac fibers.

S M Yabek, R Kato, N Ikeda, B N Singh.   

Abstract

The acute cellular electrophysiologic actions of flecainide acetate on isolated neonatal and adult canine ventricular myocardium and Purkinje fibers were evaluated with standard microelectrode techniques. Flecainide, 0.1 to 10.0 micrograms/ml, produced concentration-dependent decreases in action potential amplitude, overshoot, and phase O Vmax of adult ventricular myocardium and Purkinje fibers. The greatest effects were on Vmax. Neonatal action potential characteristics were affected to a lesser degree by flecainide. Flecainide had disparate effects on myocardial and Purkinje fiber repolarization and refractoriness. In adult ventricular myocardium, action potential duration (APD) and effective refractory period (ERP) increased progressively with drug concentration. APD and ERP were increased to a lesser degree in neonatal myocardium. In adult Purkinje fibers, APD decreased progressively with increasing flecainide concentrations. ERP decreased at 0.1 and 1.0 microgram/ml, but returned to control values at 10.0 micrograms/ml. APD and ERP of neonatal Purkinje fibers responded to a lesser degree. At faster stimulation frequencies (2 to 4 Hz), flecainide produced significant frequency-dependent decreases in Vmax in adult Purkinje fibers. Such use-dependency was not evident in neonatal fibers. These data indicate a significantly lower sensitivity of immature cardiac tissues to the electrophysiologic effects of flecainide.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3099562     DOI: 10.1016/0002-8703(87)90011-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

1.  A computational model to predict the effects of class I anti-arrhythmic drugs on ventricular rhythms.

Authors:  Jonathan D Moreno; Z Iris Zhu; Pei-Chi Yang; John R Bankston; Mao-Tsuen Jeng; Chaoyi Kang; Lianguo Wang; Jason D Bayer; David J Christini; Natalia A Trayanova; Crystal M Ripplinger; Robert S Kass; Colleen E Clancy
Journal:  Sci Transl Med       Date:  2011-08-31       Impact factor: 17.956

2.  Electrophysiological effects of flecainide enantiomers in canine Purkinje fibres.

Authors:  J K Smallwood; D W Robertson; M I Steinberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

3.  Sodium channel-blocking properties of flecainide, a class IC antiarrhythmic drug, in guinea-pig papillary muscles. An open channel blocker or an inactivated channel blocker.

Authors:  M Kojima; T Hamamoto; T Ban
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

4.  Flecainide in the treatment of fetal tachycardias.

Authors:  L D Allan; S K Chita; G K Sharland; D Maxwell; K Priestley
Journal:  Br Heart J       Date:  1991-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.